Abingdon Health Ltd, a UK-based diagnostic company, has obtained £3 million from a syndicate of investors led by Imperial Innovations Group Plc to support the commercialisation of its recently launched device to detect multiple myeloma. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
